CareDx Inc. | Ownership

Companies that own CareDx Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fred Alger Management, Inc.
3,262,790
8.98%
1,241,668
0.3%
06/30/2018
Gagnon Securities LLC
2,399,100
6.6%
439,075
15.26%
08/23/2018
BlackRock Fund Advisors
2,039,754
5.61%
2,002,860
0%
06/30/2018
ArrowMark Colorado Holdings LLC
1,338,568
3.68%
1,338,568
0.28%
06/30/2018
The Vanguard Group, Inc.
1,233,569
3.39%
392,712
0%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
1,230,792
3.39%
1,230,792
0.04%
06/30/2018
Next Century Growth Investors LLC
1,206,130
3.32%
-370,728
3.35%
06/30/2018
12 West Capital Management LP
1,150,000
3.16%
1,150,000
1.9%
06/30/2018
Wellington Management Co. LLP
982,646
2.7%
-182,900
0%
06/30/2018
Gagnon Advisors LLC
965,894
2.66%
10,136
13.69%
06/30/2018

About CareDx

View Profile
Address
3260 Bayshore Boulevard
Brisbane California 94005
United States
Employees -
Website http://www.caredxinc.com
Updated 07/08/2019
CareDx, Inc. operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. It focuses on discovery, development, and commercialization of diagnostic surveillance solutions. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test.